← Evidence map

ArticleDrug design, development and therapy2021

Saroglitazar - A Potential Therapeutic Option in Treating NASH? [Letter].

Syed Hasan Shuja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34675485